---
category: news
title: "NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)"
excerpt: "Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics,"
publishedDateTime: 2021-12-10T18:41:00Z
originalUrl: "https://www.digitaljournal.com/pr/nasdaq-company-advances-ai-enhanced-protein-design-technology-for-cellular-therapy-development-avalon-globocare-inc-nasdaq-avco"
webUrl: "https://www.digitaljournal.com/pr/nasdaq-company-advances-ai-enhanced-protein-design-technology-for-cellular-therapy-development-avalon-globocare-inc-nasdaq-avco"
type: article
quality: 25
heat: 25
published: false

provider:
  name: Digital Journal
  domain: digitaljournal.com

topics:
  - AI in Healthcare
  - AI
  - Google AI

images:
  - url: "https://www.digitaljournal.com/wp-content/uploads/2021/12/39a80afe153a2b21454ccec302e336bd5ba87fca-600x337.jpg"
    width: 600
    height: 337
    isCached: true

secured: "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;NhNm17qPh5+c/x3FyNKeBg=="
---

